The world knows Martin Shkreli mostly for his controversial decision to crank up the price of an essential drug by 5,000 percent, earning him the moniker “Pharma Bro.” On Sunday, his Twitter account was suspended following a series of harassment Tweets directed at a female journalist.
The journalist in question is Lauren Duca and according to unnamed sources, she has been the subject of unwanted attention from Shkreli for several days, Boston Globe reports. The whole thing reportedly started after Duca’s appearance at a Fox News show hosted by Tucker Carlson where the two butted heads.
Before coming on, Duca had written a scathing article titled “Donald Trump is gaslighting America,” which was published in Teen Vogue. The Fox News host didn’t take kindly to how the president-elect was portrayed and made it known. After appearing on the show, Duca received numerous threats. Several days later, Shkreli started Tweeting the journalist with suggestive comments.
In one post, Shkreli asked Duca to be his plus-one during Trump’s inauguration, to which she responded by Tweeting “I would rather eat my own organs.” The pharmaceutical executive followed that up by posting photoshopped images of him and Duca, which the latter found inappropriate.
As a result of his actions, Twitter decided that it would be better for Shkreli to take some time off the micro-blogging service, confirming his suspension to the media via email. After the suspension, Duca made her own Tweet, wondering at how women immediately get harassed the moment they start getting attention for their work, Reuters reports.
"Why is harassment an automatic career hazard for a woman receiving any amount of professional attention?" Duca’s Tweet reads.
Considering what Shkreli is known to have done, which led to his dismissal as head of Turing Pharmaceuticals, this news might seem benign in comparison. However, it is indicative of a habit by “Pharma Bro” to not care about what anyone thought of his actions.


SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
Meta AI Push Could Add $26 Billion in Revenue by 2027, Wolfe Research Says
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
SpaceX IPO Could Become Largest in History with $1.8 Trillion Valuation Target
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge 



